Claudio Bassi

Q: What Schools Are Affiliated With Claudio Bassi

Claudio Bassi is affiliated with the following schools: University of Liverpool, University of Calgary, University of Milan, MD Anderson Cancer Center, University of Verona, Stanford University, University of Glasgow

Claudio Bassi's AcademicInfluence.com Rankings

Claudio Bassi

Physics

#3951

World Rank

#5510

Historical Rank

physics Degrees

Download Badge

Physics

Claudio Bassi's Degrees

PhD Physics University of Milan
Masters Physics University of Milan
Bachelors Physics University of Milan

Why Is Claudio Bassi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Claudio Bassi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience (2009) (6840)
Postoperative pancreatic fistula: an international study group (ISGPF) definition. (2005) (3996)
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. (2004) (2432)
Genomic analyses identify molecular subtypes of pancreatic cancer (2016) (2343)
The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After (2017) (2307)
Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). (2007) (2164)
Whole genomes redefine the mutational landscape of pancreatic cancer (2015) (1983)
Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. (2007) (1633)
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. (2010) (1235)
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial (2001) (998)
Main-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: Clinical Predictors of Malignancy and Long-term Survival Following Resection (2004) (747)
Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). (2014) (684)
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer (2012) (661)
IAP Guidelines for the Surgical Management of Acute Pancreatitis (2003) (657)
Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. (1999) (623)
Whole-genome landscape of pancreatic neuroendocrine tumours (2017) (616)
Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial (2001) (598)
A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. (1993) (538)
Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). (2014) (469)
Guidelines for the management of acute pancreatitis (2002) (435)
Reconstruction by Pancreaticojejunostomy Versus Pancreaticogastrostomy Following Pancreatectomy: Results of a Comparative Study (2005) (421)
Early Versus Late Drain Removal After Standard Pancreatic Resections: Results of a Prospective Randomized Trial (2010) (416)
Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. (2005) (412)
Mucinous Cystic Neoplasm of the Pancreas is Not an Aggressive Entity: Lessons From 163 Resected Patients (2008) (410)
European evidence-based guidelines on pancreatic cystic neoplasms (2018) (401)
Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. (2010) (381)
Patterns of somatic structural variation in human cancer genomes (2020) (377)
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. (2007) (351)
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. (2017) (346)
Genetic profile of 22 pancreatic carcinoma cell lines (2001) (330)
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer (2004) (321)
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. (2014) (314)
ESPEN Guidelines on Parenteral Nutrition: pancreas. (2006) (301)
Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. (2008) (296)
Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? (2006) (291)
Amylase Value in Drains After Pancreatic Resection as Predictive Factor of Postoperative Pancreatic Fistula: Results of a Prospective Study in 137 Patients (2007) (289)
Duct-to-mucosa versus end-to-side pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: results of a prospective randomized trial. (2003) (283)
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. (2010) (282)
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas (2014) (276)
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial. (2014) (273)
IAP Guidelines for the Surgical Management of Acute Pancreatitis (2002) (272)
Pancreatic Fistula Rate after Pancreatic Resection (2004) (267)
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium (2019) (256)
Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas) (2015) (253)
Alcohol and Smoking as Risk Factors in Chronic Pancreatitis and Pancreatic Cancer (1999) (250)
Management of Complications after Pancreaticoduodenectomy in a High Volume Centre: Results on 150 Consecutive Patients / with Invited Commentary (2002) (249)
Pancreatic Anastomotic Leakage After Pancreaticoduodenectomy in 1,507 Patients: A Report from the Pancreatic Anastomotic Leak Study Group (2007) (244)
Laparoscopic Distal Pancreatectomy: Results on a Consecutive Series of 58 Patients (2006) (231)
Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. (1999) (227)
Middle Pancreatectomy: Indications, Short- and Long-term Operative Outcomes (2007) (224)
UK guidelines for the management of acute pancreatitis (2005) (223)
The Miami International Evidence-Based Guidelines on Minimally Invasive Pancreas Resection. (2019) (218)
Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. (2008) (215)
Early Assessment of Pancreatic Infections and Overall Prognosis in Severe Acute Pancreatitis by Procalcitonin (PCT): A Prospective International Multicenter Study (2007) (212)
Prospective randomized double‐blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer (1998) (211)
Efficacy of octreotide in the prevention of complications of elective pancreatic surgery (1994) (211)
Gene expression profiles of pancreatic cancer and stromal desmoplasia (2001) (210)
Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis (2001) (210)
Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External Validation (2017) (210)
Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS). (2014) (206)
Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis. (1998) (205)
Incidence of cancer in the course of chronic pancreatitis (1999) (200)
Management of 100 Consecutive Cases of Pancreatic Serous Cystadenoma: Wait for Symptoms and See at Imaging or Vice Versa? (2003) (199)
Comprehensive molecular characterization of mitochondrial genomes in human cancers (2017) (197)
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials (2009) (196)
Efficacy of octreotide in the prevention of complications of elective pancreatic surgery (1994) (189)
Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting. (2016) (188)
Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas (2001) (183)
Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer (2010) (180)
Pancreatic fistula rate after pancreatic resection. The importance of definitions. (2004) (179)
Pancreatic anastomosis after pancreatoduodenectomy: A position statement by the International Study Group of Pancreatic Surgery (ISGPS) (2017) (176)
Definition and classification of chyle leak after pancreatic operation: A consensus statement by the International Study Group on Pancreatic Surgery (2017) (174)
Symptoms and Quality of Life in Chronic Pancreatitis Assessed by Structured Interview and the EORTC QLQ-C30 and QLQ-PAN26 (2005) (173)
Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies (2012) (172)
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer (2018) (170)
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups (2014) (161)
Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis (2016) (160)
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched Study (2017) (159)
Enucleation of pancreatic neoplasms (2007) (157)
Clinicopathological Correlates of Activating GNAS Mutations in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas (2013) (156)
Italian consensus guidelines for chronic pancreatitis. (2010) (155)
Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk Stratification (2017) (146)
Randomized, multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma: including a prospective evaluation of the role of hENT1 in gemcitabine or CO-101 sensitivity. (2013) (143)
Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation (2016) (143)
High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma (2003) (142)
Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons. (2019) (141)
Cigarette Smoking: An Independent Risk Factor in Alcoholic Pancreatitis (1996) (138)
Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory Process (2010) (137)
Resectable Pancreatic Cancer: Who Really Benefits From Resection? (2009) (136)
Adjuvant therapy in pancreatic cancer: historical and current perspectives. (2003) (134)
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. (2013) (134)
Practical Guidelines for Acute Pancreatitis (2010) (133)
Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin. (1986) (130)
Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS) (2018) (129)
Natural History of Intraductal Papillary Mucinous Neoplasms (IPMN): Current Evidence and Implications for Management (2008) (128)
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan (2019) (126)
Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers (2005) (125)
When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery. (2014) (123)
Pancreatic fistula: definition and current problems. (2008) (123)
Pancreatic resections for cystic neoplasms: from the surgeon's presumption to the pathologist's reality. (2012) (120)
Behavior of antibiotics during human necrotizing pancreatitis (1994) (119)
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group (2017) (118)
Prospective multicentre survey on acute pancreatitis in Italy (ProInf-AISP): results on 1005 patients. (2004) (116)
Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study (2015) (115)
Efficacy of an Absorbable Fibrin Sealant Patch (TachoSil) After Distal Pancreatectomy: A Multicenter, Randomized, Controlled Trial (2012) (114)
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy (2014) (113)
Clinical and biological behavior of pancreatic solid pseudopapillary tumors: Report on 31 consecutive patients (2007) (110)
Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. (2011) (109)
Acute pancreatitis at the beginning of the 21st century: the state of the art. (2009) (109)
Parenchyma-Preserving Resections for Small Nonfunctioning Pancreatic Endocrine Tumors (2010) (109)
Risk Factors for Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas: A Multicentre Case–Control Study (2013) (108)
The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy (2016) (107)
Effect of Alcohol and Smoking on Pancreatic Lithogenesis in the Course of Chronic Pancreatitis (1994) (107)
Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy (2017) (105)
Risk of death from acute pancreatitis (1996) (105)
Delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy: validation of International Study Group of Pancreatic Surgery classification and analysis of risk factors. (2010) (104)
Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells (2003) (104)
Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. (2013) (103)
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 (2019) (102)
Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. (2007) (101)
Long-term follow-up of patients with chronic pancreatitis in Italy. (1998) (101)
“Paraduodenal” Pancreatitis: Results of Surgery on 58 Consecutives Patients from a Single Institution (2009) (101)
Growth pattern of serous cystic neoplasms of the pancreas: observational study with long-term magnetic resonance surveillance and recommendations for treatment (2011) (100)
Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? (2001) (95)
Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms (2002) (95)
Drain Management after Pancreatoduodenectomy: Reappraisal of a Prospective Randomized Trial Using Risk Stratification. (2015) (94)
Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma (2012) (93)
Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas (2017) (91)
Prospective comparison of C‐reactive protein level, Ranson score and contrast‐enhanced computed tomography in the prediction of septic complications of acute pancreatitis (1993) (90)
Prognostic Relevance of Lymph Node Ratio and Number of Resected Nodes after Curative Resection of Ampulla of Vater Carcinoma (2008) (90)
Discordance Between Perioperative Antibiotic Prophylaxis and Wound Infection Cultures in Patients Undergoing Pancreaticoduodenectomy. (2016) (90)
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer (2018) (88)
Serum creatinine and chest radiographs in the early assessment of acute pancreatitis. (1999) (87)
ESPAC-3(v2): A multicenter, international, open-label, randomized controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma. (2009) (87)
Postoperative Acute Pancreatitis Following Pancreaticoduodenectomy: A Determinant of Fistula Potentially Driven by the Intraoperative Fluid Management (2018) (82)
Long-term outcome of acute pancreatitis: a prospective study with 118 patients. (1993) (81)
Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy (2017) (81)
Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer. (2015) (79)
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. (2009) (79)
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma. (2019) (78)
Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. (2012) (78)
Microbiological findings in severe pancreatitis (1989) (78)
Diagnosis and management of postoperative pancreatic fistula (2014) (78)
Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors. (2014) (77)
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections (2017) (77)
Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts. (2009) (77)
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? (2017) (76)
Autoimmune Pancreatitis: Possibilities of CT Characterization (2001) (75)
Alcohol, smoking and papillomavirus infection as risk factors for esophageal squamous‐cell papilloma and esophageal squamous‐cell carcinoma in Italy (2000) (75)
Contrast-Enhanced Ultrasonography of the Pancreas (2007) (75)
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer. (2016) (74)
Perioperative and long‐term results of laparoscopic spleen‐preserving distal pancreatectomy with or without splenic vessels conservation: A retrospective analysis (2012) (74)
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications (2018) (73)
Defining the practice of pancreatoduodenectomy around the world. (2015) (73)
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review (2016) (73)
Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial. (2020) (71)
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. (2004) (71)
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM (2017) (69)
Smoking Cessation at the Clinical Onset of Chronic Pancreatitis and Risk of Pancreatic Calcifications (2007) (68)
Invasive Intraductal Papillary Mucinous Carcinomas of the Pancreas: Predictors of Survival and the Role of Lymph Node Ratio (2010) (68)
A grading system can predict clinical and economic outcomes of pancreatic fistula after pancreaticoduodenectomy: results in 755 consecutive patients (2010) (68)
The determinant factors of recurrence following resection for ductal pancreatic cancer. (2007) (68)
Modifications in the International Study Group for Pancreatic Surgery (ISGPS) definition of postoperative pancreatic fistula. (2017) (67)
Influence of Surgical Resection and Post-Operative Complications on Survival following Adjuvant Treatment for Pancreatic Cancer in the ESPAC-1 Randomized Controlled Trial (2006) (67)
Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.) (1993) (66)
Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters. (2016) (66)
Outcomes and Risk Score for Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): An International Multicenter Analysis (2019) (65)
Pancreatic Cystic Endocrine Tumors: A Different Morphological Entity Associated with a Less Aggressive Behavior (2010) (65)
Retroperitoneal and peritoneal drainage and lavage in the treatment of severe necrotizing pancreatitis. (1990) (63)
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm. (2015) (63)
Anastomotic leakage in pancreatic surgery. (2007) (62)
Infected Pancreatic Necrosis and Peripancreatic Fluid Collections: Serendipitous Response to Antibiotics and Medical Therapy in Three Patients (1996) (62)
Complications after pancreaticoduodenectomy: the problem of current definitions. (2006) (61)
Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma (2012) (61)
Toward improving uniformity and standardization in the reporting of pancreatic anastomoses: a new classification system by the International Study Group of Pancreatic Surgery (ISGPS). (2010) (61)
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases (2018) (61)
Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study (2018) (61)
Pan-European survey on the implementation of minimally invasive pancreatic surgery with emphasis on cancer. (2016) (60)
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence (2016) (59)
Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors? (2015) (59)
Diffusion-weighted imaging of pancreatic cancer. (2015) (58)
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases. (2020) (58)
Aggressive approach to acinar cell carcinoma of the pancreas: a single-institution experience and a literature review (2011) (58)
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials). (2014) (58)
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high‐volume center (2017) (57)
TERT gene harbors multiple variants associated with pancreatic cancer susceptibility (2015) (54)
Prospective randomised pilot study of management of the pancreatic stump following distal resection (1999) (54)
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment. (2020) (54)
Systematic review, meta‐analysis, and a high‐volume center experience supporting the new role of mural nodules proposed by the updated 2017 international guidelines on IPMN of the pancreas (2018) (53)
The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3 (2002) (52)
Intraductal Papillary Mucinous Neoplasms and Chronic Pancreatitis (2007) (52)
The prognostic impact of para-aortic lymph node metastasis in pancreatic cancer: A systematic review and meta-analysis. (2016) (51)
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up (2015) (51)
Radiofrequency ablation of locally advanced pancreatic adenocarcinoma: an overview. (2010) (51)
Infected pancreatic necrosis (1994) (51)
Preoperative Pancreatic Resection (PREPARE) Score: A Prospective Multicenter-Based Morbidity Risk Score (2014) (51)
Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma. (2019) (50)
Lactobacillus plantarum Reduces Infection of Pancreatic Necrosis in Experimental Acute Pancreatitis (2001) (49)
Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis. (1995) (49)
Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Italy. Italian Study Group. (1994) (48)
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas. (2010) (47)
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients. (2017) (47)
Patterns of Recurrence after Resection for Pancreatic Neuroendocrine Tumors: Who, When, and Where? (2018) (47)
CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms (2019) (46)
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? (2019) (46)
Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. (2013) (46)
Evidence‐based assessment of severity and management of acute pancreatitis (2000) (46)
Thoracic Complications of Pancreatitis (1989) (46)
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution (2017) (45)
Triple approach strategy for patients with locally advanced pancreatic carcinoma. (2013) (45)
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. (2013) (45)
Methylation Dynamics of RASSF1A and Its Impact on Cancer (2019) (45)
European Study Group for Pancreatic Cancer‐1 interim results: a European randomized study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer (2001) (44)
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis (2014) (44)
Long-term results of frey’s procedure for chronic pancreatitis: a longitudinal prospective study on 40 patients (2006) (43)
Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. (2003) (43)
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models (2013) (43)
Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External Validation (2017) (43)
ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer. (1997) (42)
Short term chemotherapy followed by radiofrequency ablation in stage III pancreatic cancer: results from a single center (2013) (42)
Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results (2017) (42)
Sex differences in oncogenic mutational processes (2019) (41)
SEL1L expression in pancreatic adenocarcinoma parallels SMAD4 expression and delays tumor growth in vitro and in vivo (2003) (41)
Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group (2011) (41)
Surgical Treatment of Pancreatic Metastases from Renal Cell Carcinomas (1998) (39)
Pancreatic cystic manifestations in von Hippel-Lindau disease (1997) (39)
Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis (2021) (38)
Effects of Dietary Components on Cancer of the Digestive System (2015) (38)
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies (2015) (38)
A single-institution experience with fistulojejunostomy for external pancreatic fistulas. (2000) (38)
Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer. (2004) (37)
Pancreaticoduodenectomy for pancreatic cancer: The Verona experience (2011) (37)
C-Reactive Protein and Procalcitonin as Predictors of Postoperative Inflammatory Complications After Pancreatic Surgery (2016) (37)
Perioperative and long-term results after left pancreatectomy: a single-institution, non-randomized, comparative study between open and laparoscopic approach (2011) (37)
Percutaneous ablation of pancreatic cancer (2016) (36)
A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula (2021) (36)
Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS). (2020) (36)
Pancreatic Hepatoid Carcinoma: A Review of the Literature (2013) (36)
Molecular pathogenesis of sporadic duodenal cancer. (1998) (36)
Open pancreaticogastrostomy after pancreaticoduodenectomy: A pilot study (2006) (36)
Cytoreductive surgery in advanced endocrine tumours of the pancreas. (1999) (35)
Early Detection of Pancreatic Cancer following the Diagnosis of Chronic Pancreatitis (1999) (35)
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases (2020) (35)
Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data. (2019) (34)
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors (2019) (34)
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results. (2018) (34)
Middle-preserving pancreatectomy for multicentric body-sparing lesions of the pancreas. (2009) (34)
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration. (2017) (34)
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations (2018) (34)
Role of Chemoembolization in Synchronous Liver Metastases from Pancreatic Endocrine Tumours (1999) (34)
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma (2018) (34)
Pain relapses in the first 10 years of chronic pancreatitis. (1996) (34)
Effectiveness of gabexate mesilate in acute pancreatitis (1995) (33)
Outcome of Open Necrosectomy in Acute Pancreatitis (2003) (33)
Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC): An International Delphi Study Among Patients and Health Care Providers. (2017) (32)
Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential. (2019) (32)
Predictive factors for postoperative pancreatic fistula. (2015) (32)
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies. (2017) (32)
Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer—Subset analysis of the ESPAC‐1 data (2009) (31)
Pancreaticojejunostomy after pancreaticoduodenectomy: Suture material and incidence of post-operative pancreatic fistula. (2016) (31)
Middle Segment Pancreatectomy: A Useful Tool in the Management of Pancreatic Neoplasms (2007) (31)
Intraductal papillary mucinous neoplasms (IPMNs): is it time to (sometimes) spare the knife? (2008) (30)
Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry (2018) (30)
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases. (2019) (30)
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma (2017) (30)
Importance of main pancreatic duct dilatation in IPMN undergoing surveillance (2018) (30)
Progress report: A randomized multicenter European stydy comparing adjuvant radiotherapy, 6 Mo chemotherapy, and combination therapy vs No-adjuvant treatment in resectable pancreatic cancer (ESPAC-1) (1997) (29)
Modelling centralization of pancreatic surgery in a nationwide analysis (2020) (29)
Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors: Implications for Managing Surgical Decisions (2017) (29)
Pseudopapillary tumor in pediatric age: clinical and surgical management (2011) (29)
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis. (2019) (29)
Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection (2018) (29)
Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile? (2012) (28)
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma (2019) (28)
Virtual Analysis of Pancreatic Cystic Lesion Fluid Content by Ultrasound Acoustic Radiation Force Impulse Quantification (2013) (28)
Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes (2015) (28)
Reappraisal of post-pancreatectomy hemorrhage (PPH) classifications: do we need to redefine grades A and B? (2018) (28)
Main Duct Dilatation Is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas. (2019) (27)
Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine (2020) (26)
Surgical management of acute pancreatitis in Italy: lessons from a prospective multicentre study. (2010) (26)
Minimally invasive pancreatic surgery – a review (2015) (26)
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal. (2018) (26)
Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation. (2018) (26)
Gemcitabine‐based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score‐matched cohort study (2020) (26)
Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma. (2013) (26)
Defining Benchmark Outcomes for Pancreatoduodenectomy With Portomesenteric Venous Resection. (2020) (25)
Laparoscopic pancreatectomy for solid pseudo-papillary tumors of the pancreas is a suitable technique; our experience with long-term follow-up and review of the literature. (2011) (25)
Alcohol Intake, Cigarette Smoking, and Body Mass Index in Patients with Alcohol-associated Pancreatitis (2000) (25)
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study (2020) (25)
Clinical Implications of Intraoperative Fluid Therapy in Pancreatic Surgery (2018) (25)
Pancreatic surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it (2016) (25)
Outcome and quality of life in chronic pancreatitis. (2001) (24)
Drain management after pancreatic resection: state of the art (2011) (24)
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques, and Outcomes (2021) (24)
Changes in pancreatic resection for chronic pancreatitis over 28 years in a single institution (2000) (24)
Ciprofloxacin penetration in pancreatic juice. (1987) (24)
Motility Analysis of Pancreatic Adenocarcinoma Cells Reveals a Role for the Atypical ζ Isoform of Protein Kinase C in Cancer Cell Movement (2003) (23)
High-risk Pancreatic Anastomosis vs. Total Pancreatectomy after Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis. (2021) (23)
Runx2 expression: A mesenchymal stem marker for cancer. (2016) (23)
Adequacy of Lymph Node Retrieval for Ampullary Cancer and Its Association with Improved Staging and Survival (2013) (23)
Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma. (2016) (23)
Association between pancreatic intraductal papillary mucinous neoplasms and extrapancreatic malignancies. (2015) (23)
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics (1996) (23)
Lymph nodes metastasis and recurrences justify an aggressive treatment of gastrinoma (2013) (22)
Pefloxacin penetration into human necrotic pancreatic tissue. (1996) (22)
Identifying key outcome metrics in pancreatic surgery, and how to optimally achieve them. (2017) (22)
Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? (2017) (22)
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (22)
Evolving the Paradigm of Early Drain Removal Following Pancreatoduodenectomy (2018) (21)
Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies (2017) (21)
Pancreaticoduodenectomy with Harmonic Focust Curved Shears for Cancer (2014) (21)
Clinical and Morphological Features of Paraduodenal Pancreatitis: An Italian Experience With 120 Patients (2017) (21)
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients (2017) (21)
PREPARE: PreoPerative Anxiety REduction. One-Year Feasibility RCT on a Brief Psychological Intervention for Pancreatic Cancer Patients Prior to Major Surgery (2020) (21)
Pancreatic fistula risk for pancreatoduodenectomy: an international survey of surgeon perception. (2017) (21)
Postoperative hyperamylasemia (POH) and acute pancreatitis after pancreatoduodenectomy (POAP): State of the art and systematic review. (2020) (20)
Prophylaxis for septic complications in acute necrotizing pancreatitis. (2001) (20)
Clinical implications of biological markers in Pancreatic Ductal Adenocarcinoma. (2012) (20)
Non‐inferiority of open passive drains compared with closed suction drains in pancreatic surgery outcomes: A prospective observational study (2018) (20)
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN “colour-and-resect the pancreas” study (2017) (20)
A multicenter survey on distal pancreatectomy in Italy: results of minimally invasive technique and variability of perioperative pathways (2014) (20)
Intraductal papillary mucinous tumors of the pancreas. Verona University Pancreatic Team. (2000) (20)
Poor Results of Pancreatoduodenectomy in High-Risk Patients with Endoscopic Stent and Bile Colonization are Associated with E. coli, Diabetes and Advanced Age (2016) (19)
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? (2018) (19)
Molecular Approaches To Target GPCRs in Cancer Therapy (2011) (19)
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center (2017) (19)
Prognostication and response assessment in liver and pancreatic tumors: The new imaging. (2015) (19)
Pancreatectomy with Para-Aortic Lymph Node Dissection for Pancreatic Head Adenocarcinoma: Pattern of Nodal Metastasis Spread and Analysis of Prognostic Factors (2015) (19)
Role of octreotide in the treatment of external pancreatic pure fistulas: a single-institution prospective experience (2000) (19)
Robotic spleen-preserving distal pancreatectomy: the Verona experience (2020) (19)
Quantitative Assessment of Pancreatic Texture Using a Durometer: A New Tool to Predict the Risk of Developing a Postoperative Fistula (2017) (19)
HENT1 tumor levels to predict survival of pancreatic ductal adenocarcinoma patients who received adjuvant gemcitabine and adjuvant 5FU on the ESPAC trials. (2013) (19)
The Fistula Risk Score Catalog (2020) (19)
Perioperative management of patients undergoing pancreatic resection: Implementation of a care plan in a tertiary‐care center (2013) (19)
Evidence Map of Pancreatic Surgery-A living systematic review with meta-analyses by the International Study Group of Pancreatic Surgery (ISGPS). (2021) (19)
Long term outcome after minimally invasive and open Warshaw and Kimura techniques for spleen-preserving distal pancreatectomy: International multicenter retrospective study. (2019) (19)
Cyst fluid SPINK1 may help to differentiate benign and potentially malignant cystic pancreatic lesions. (2013) (18)
Role of fistulography in evaluating pancreatic fistula after pancreaticoduodenectomy. (2012) (18)
Pancreatic ductal adenocarcinoma can be detected by analysis of volatile organic compounds (VOCs) in alveolar air (2018) (18)
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial (2020) (18)
Intraductal papillary mucinous tumors of the pancreas (2000) (18)
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay (2018) (18)
Necrosectomy by lavage in the surgical treatment of severe necrotizing pancreatitis. Results in 263 patients. (1990) (18)
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience (2017) (18)
Chronic pancreatitis: relationship to acute pancreatitis and pancreatic cancer. (2000) (18)
Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study (2019) (17)
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal. (2019) (17)
Management of Pancreatic Cystic Lesions (2019) (17)
Time trends in the treatment and prognosis of resectable pancreatic cancer in a large tertiary referral centre. (2013) (17)
Intraductal papillary mucinous tumors of the pancreas. Surgical treatment: at what point should we stop? (2005) (17)
Pancreatic abscess and other pus-harboring collections related to pancreatitis: A review of 108 cases (1990) (17)
Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma (2018) (17)
Previous Cholecystectomy, Gastrectomy, and Diabetes Mellitus are not Crucial Risk Factors for Pancreatic Cancer in Patients with Chronic Pancreatitis (2001) (17)
Characterization of postoperative acute pancreatitis (POAP) after distal pancreatectomy. (2020) (17)
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery (2020) (17)
Blunt Pancreatic Trauma (1997) (16)
Role of somatostatin and somatostatin analogues in the treatment of gastrointestinal diseases: prevention of complications after pancreatic surgery. (1994) (16)
Antibacterial and mezlocillin-enhancing activity of pure human pancreatic fluid (1991) (16)
The curious case of Gαs gain-of-function in neoplasia (2018) (16)
Current Definition of and Controversial Issues Regarding Postoperative Pancreatic Fistulas (2018) (16)
Infection prevention in necrotizing pancreatitis: an old challenge with new perspectives. (2001) (16)
Prevent Pancreatic Fistula after Pancreatoduodenectomy: Possible Role of Ultrasound Elastography (2017) (16)
Pancreatic calcifications in patients with chronic pancreatitis. A sign of long-lasting or severe disease? (1990) (16)
MicroRNA from Pancreatic Duct Aspirate Differentiates Cystic Lesions of the Pancreas (2013) (16)
Ofloxacin penetration into bile and pancreatic juice. (1989) (16)
Endoscopic placement of pancreatic stent for “Deep” pancreatic enucleations operative technique and preliminary experience at two high-volume centers (2020) (16)
Assessment of a Complication Risk Score and Study of Complication Profile in Laparoscopic Distal Pancreatectomy (2014) (15)
Preoperative Imaging Evaluation after Downstaging of Pancreatic Ductal Adenocarcinoma: A Multi-Center Study (2019) (15)
Outcome of superior mesenteric-portal vein resection during pancreatectomy for borderline ductal adenocarcinoma: results of a prospective comparative study (2014) (15)
Value of regional lymphadenectomy in pancreatic cancer. (2005) (15)
Middle Segment Pancreatectomy: A Useful Tool in the Management of Pancreatic Neoplasms (2007) (15)
Long term outcome of acute pancreatitis in Italy: results of a multicentre study. (2013) (15)
Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery. (2021) (15)
Clinical impact of the updated international postoperative pancreatic fistula definition in distal pancreatectomy. (2018) (15)
Uncommon presentations of common pancreatic neoplasms: a pictorial essay (2015) (15)
Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development. (2020) (15)
Carcinoma of pancreatic body and tail: are there improvements in diagnosis and treatment modalities over the past decade? (2003) (15)
Somatostatin analogues and pancreatic fistulas. (1996) (14)
Implementation of a strategic preoperative surgical meeting to improve the level of care at a high-volume pancreatic center: a before–after analysis of 1000 consecutive cases (2020) (14)
Pancreatic resections for cystic neoplasms: From the surgeon's presumption to the pathologist's reality (2012) (14)
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary (2018) (14)
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma (2020) (14)
Preoperative fecal elastase-1 (FE-1) adds value in predicting post-operative pancreatic fistula: not all soft pancreas share the same risk - A prospective analysis on 105 patients. (2019) (14)
International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for pancreatic cancer. (2019) (14)
Prognostic Factors in Patients With Advanced Pancreatic Adenocarcinoma Treated With Intra-Arterial Chemotherapy (2008) (14)
Meta‐analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy: Authors' comment (Br J Surg 2006; 93: 929–936) (2006) (14)
Defining the practice of distal pancreatectomy around the world. (2018) (14)
Discussion on prophylactic antibiotic treatment in patients with predicted severe pancreatitis: a placebo-controlled, double-blind trial. (2004) (13)
Facing the Pancreatic Dilemma (1994) (13)
Perioperative Interstitial Fluid Expansion Predicts Major Morbidity Following Pancreatic Surgery: Appraisal by Bioimpedance Vector Analysis. (2019) (13)
Ezrin Expression Is an Independent Prognostic Factor in Gastro-intestinal Cancers (2013) (13)
Randomized multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) and a prospective evaluation of the of the association between tumor hENT1 expression and clinical outcome with gemcitabine treatment. (2013) (13)
Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer. (2020) (13)
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy (2021) (13)
Preconditioning with hyperbaric oxygen in pancreaticoduodenectomy: a randomized double-blind pilot study. (2014) (13)
Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer (2016) (13)
Overexpression of the Sm-like proto-oncogene in primary and metastatic pancreatic endocrine tumors. (2002) (13)
ERCP in acute pancreatitis: What takes place in routine clinical practice? (2010) (13)
Cystic tumours of the pancreas: a review. (2001) (13)
Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected Cases (2021) (13)
Residual pancreatic function after pancreaticoduodenectomy is better preserved with pancreaticojejunostomy than pancreaticogastrostomy: A long-term analysis. (2019) (13)
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity Results from a Single-Center Surgical Series (2017) (13)
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma (2013) (13)
Decision points in pancreatoduodenectomy: Insights from the contemporary experts on prevention, mitigation, and management of postoperative pancreatic fistula. (2021) (13)
Endoscopic transmural drainage of pseudocysts associated with pancreatic resections or pancreatitis: a comparative study (2011) (13)
The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer (2020) (12)
The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy (2020) (12)
Pancreatic cystic tumours: when to resect, when to observe. (2010) (12)
A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma (2000) (12)
The influence of fellowship training on the practice of pancreatoduodenectomy. (2016) (12)
Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma (2021) (12)
CFTR mutations and IV58-5T prevalence in idiopathic chronic and acute recurrent pancreatitis (1998) (12)
Preoperative risk stratification of postoperative pancreatic fistula: A risk-tree predictive model for pancreatoduodenectomy. (2021) (12)
Use of an intraoperative wound protector to prevent surgical‐site infection after pancreatoduodenectomy: randomized clinical trial (2020) (12)
Pancreaticoduodenectomy for paraduodenal pancreatitis is associated with a higher incidence of diabetes but a similar quality of life and pain control when compared to medical treatment. (2020) (12)
Postpancreatectomy Acute Pancreatitis (PPAP) (2021) (12)
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma (2020) (12)
The role of surgery in the major early complications of severe acute pancreatitis. (1997) (12)
Intra-Arterial Chemotherapy for Stage-lll/IV Pancreatic Cancer (1997) (11)
In vivo Octreotide Administration Acutely Reduces Exocrine Granule Size in the Human Pancreas (2001) (11)
Obstructive chronic pancreatitis and/or intraductal papillary mucinous neoplasms (IPMNs): a 21-year long case report. (2006) (11)
Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learning (2020) (11)
Effects of choline-esterase inhibitor in experimental acute pancreatitis in rats (1993) (11)
Cystic "feminine" pancreatic neoplasms in men. Do any clinical alterations correlate with these uncommon entities? (2013) (11)
Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase I-II study. (2004) (11)
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer (2022) (11)
Preoperative adiposity at bioimpedance vector analysis improves the ability of Fistula Risk Score (FRS) in predicting pancreatic fistula after pancreatoduodenectomy. (2020) (11)
Prevention, prediction, and mitigation of postoperative pancreatic fistula. (2021) (11)
Pancreatic calcifications in patients with chronic pancreatitis (1990) (11)
The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter Analysis (2021) (11)
Evaluation of UICC TNM classification for pancreatic cancer (1997) (11)
Polyester sutures for pancreaticojejunostomy protect against postoperative pancreatic fistula: a case-control, risk-adjusted analysis. (2018) (11)
Dislocation of intra-abdominal drains after pancreatic surgery: results of a prospective observational study (2018) (11)
Pros and pitfalls of externalized trans-anastomotic stent as a mitigation strategy of POPF: a prospective risk-stratified observational series. (2020) (10)
Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater. (2011) (10)
Gabexate mesilate in the treatment of acute pancreatitis. (1995) (10)
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment. (2017) (10)
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification (2018) (10)
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors (2017) (10)
Development of ductal adenocarcinoma during follow-up of branch-duct IPMNs. (2009) (10)
A Surface Plasmon Resonance Plastic Optical Fiber Biosensor for the Detection of Pancreatic Amylase in Surgically-Placed Drain Effluent (2021) (10)
Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings (2016) (10)
Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis. (2021) (10)
Clinicopathological features of adenosquamous pancreatic cancer (2011) (10)
Cystic Neoplasm of the Pancreas (2015) (10)
Early and Sustained Elevation in Serum Pancreatic Amylase Activity (2021) (9)
Pancreaticoduodenal graft in the rat: an original microsurgical technique. (1989) (9)
[Intermediate resection and distal pancreatectomy for benign neoplasms of the pancreas: comparison of postoperative complications and costs]. (2001) (9)
Risk of malignancy in small pancreatic cysts decreases over time. (2020) (9)
Continuous peritoneal dialysis in acute experimental pancreatitis in dogs (1989) (9)
Pancreatic head mass, how can we treat it? Chronic pancreatitis: surgical treatment. (2000) (9)
Systematic review and meta-analysis of observational studies on BD-IPMNS progression to malignancy. (2021) (9)
What preoperative assessment is necessary for insulinomas? Calculating the degree of waste: analysis of 29 cases. (2002) (9)
Is Routine Imaging Necessary After Pancreatic Resection?: An Appraisal of Postoperative Ultrasonography for the Detection of Pancreatic Fistula (2014) (9)
Predictors for Survival in an International Cohort of Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma (2020) (9)
Prognostic Role of Examined and Positive Lymph Nodes after Distal Pancreatectomy for Non-Functioning Neuroendocrine Neoplasms (2020) (9)
Pancreatic surgery during COVID-19 pandemic: major activity disruption of a third-level referral center during 2020 (2021) (9)
Infections in Pancreatic Inflammatory Disease: Clinical Trials for Antibiotic Prophylaxis (2001) (9)
Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. (2013) (9)
Pancreas: Reconstruction methods after pancreaticoduodenectomy (2013) (9)
The Role of Laparoscopy in Advanced Pancreatic Cancer Diagnosis (2007) (8)
Does size matter in pancreatic cancer? Reappraisal of tumour dimension as a predictor of outcome beyond the TNM (2016) (8)
Standards for reporting on surgery for chronic pancreatitis: a report from the International Study Group for Pancreatic Surgery (ISGPS). (2020) (8)
Very high serum levels of CA 19‐9 in autoimmune pancreatitis: Report of four cases and brief review of literature (2016) (8)
International validation of the 8th edition American joint committee on cancer (AJCC) TNM staging system in patients with resected pancreatic cancer (2018) (8)
Management of digestive tract fistulas. A review. (1999) (8)
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial (2020) (8)
Recurrent acute pancreatitis in bowel malrotation. (2016) (8)
Ablation treatments in unresectable pancreatic cancer. (2019) (8)
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides. (2004) (8)
Does the extent of lymphatic resection affect the outcome in pancreatic cancer? (1997) (8)
The role of age in pancreatic intraductal papillary mucinous neoplasms of the pancreas: Same risk of death but different implications for management. (2018) (8)
Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy (2021) (8)
The Clinical Management of Main Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas (2018) (8)
Management of Digestive Tract Fistulas (1999) (8)
Evaluation of lanreotide effects on human exocrine pancreatic secretion after a single dose: preliminary study. (2002) (8)
Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar (2020) (8)
The Actual Prevalence of Symptoms in Pancreatic Cystic Neoplasms: A Prospective Propensity Matched Cohort Analysis (2018) (8)
Evolving pancreatic cancer treatment: From diagnosis to healthcare management (2021) (8)
Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative study. (2020) (8)
Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study. (2020) (8)
GNAS Mutations: Drivers or Co-Pilots? Yet, Promising Diagnostic Biomarkers. (2016) (8)
Minimally invasive surgery for pancreatic cancer (2019) (8)
To what extent is surgery superior to endoscopic therapy in the management of chronic pancreatitis? (1998) (7)
Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward (2021) (7)
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making (2022) (7)
Patterns of mortality after pancreatoduodenectomy: A root cause, day-to-day analysis. (2022) (7)
Benchmarking of minimally invasive distal pancreatectomy with splenectomy: European multicentre study. (2022) (7)
Polyester Preserves the Highest Breaking Point After Prolonged Incubation in Pancreatic Juice (2018) (7)
Robotic pancreatectomies (2016) (7)
Derivative Surgical Treatment (1994) (7)
Ultrasonic Dissection Versus Conventional Dissection Techniques in Pancreatic Surgery: A Randomized Multicentre Study (2012) (7)
Assessment and treatment of severe pancreatitis. Protease inhibitor. (1999) (7)
Negative pressure wound therapy for prevention of surgical site infection in patients at high risk after clean-contaminated major pancreatic resections: A single-center, phase 3, randomized clinical trial. (2020) (7)
Pancreatic cancer – What's next? (2019) (7)
Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution? (2020) (7)
Prospective study of the detection and treatment of small tumors of the head of the pancreas (1995) (6)
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance. (2021) (6)
Symptomatic stone in the duodenum after gastrectomy. (2001) (6)
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer (2020) (6)
Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction. (2013) (6)
Assessment and Treatment of Severe Pancreatitis (1999) (6)
Use of antibiotics in necrotizing pancreatitis (1996) (6)
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours (2017) (6)
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up (2021) (6)
Pancreatic surgery is a safe teaching model for tutoring residents in the setting of a high-volume academic hospital: a retrospective analysis of surgical and pathological outcomes. (2020) (6)
GNA15 expression in small intestinal neuroendocrine neoplasia: functional and signalling pathway analyses. (2015) (6)
Preoperative standardized phase angle at bioimpedance vector analysis predicts the outbreak of antimicrobial-resistant infections after major abdominal oncologic surgery: A prospective trial. (2021) (6)
Early complications of severe acute pancreatitis (2001) (6)
Surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it (2016) (6)
[Quality of life assessment in pancreatic carcinoma: results of an European multicentric study]. (1999) (6)
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma (2020) (6)
Pancreatic Cancer in the Era of Neoadjuvant Therapy: A Narrative Overview. (2018) (6)
The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis. (2021) (6)
Neoadjuvant therapy followed by resection versus upfront resection for pancreatic cancer: the actual spectrum and clinical burden of postoperative complications (2017) (6)
Over 700 Whipples for Pancreaticobiliary Malignancies: Postoperative Morbidity Is an Additional Negative Prognostic Factor for Distal Bile Duct Cancer (2017) (6)
Need for a Standard Report and Future Directions in Pancreatic Resections for Cancer (1999) (6)
Effect of hyperbaric oxygenation and gemcitabine on apoptosis of pancreatic ductal tumor cells in vitro. (2013) (6)
Coronary Artery Stent for Securing High-risk Pancreatico-jejunal Anastomosis After Pancreatoduodenectomy (2021) (6)
Pancreatoduodenectomy in obese patients: surgery for nonmalignant tumors might be deferred (2021) (6)
Magnetic resonance (MR) for mural nodule detection studying Intraductal papillary mucinous neoplasms (IPMN) of pancreas: Imaging-pathologic correlation. (2020) (5)
US-Guided Percutaneous Radiofrequency Ablation of Locally Advanced Pancreatic Adenocarcinoma: A 5-Year High-Volume Center Experience (2020) (5)
Outcomes of patients undergoing elective liver and pancreas cancer surgery during the SARS-CoV-2 pandemic: an international, multicentre, prospective cohort study (2022) (5)
The unsolved mystery of Johann Georg Wirsung and of (his?) pancreatic duct. (2011) (5)
Circulating tumour DNA: a challenging innovation to develop “precision onco-surgery” in pancreatic adenocarcinoma (2022) (5)
Predictors of pancreatic fistula healing time after distal pancreatectomy (2020) (5)
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. (2014) (5)
PANCREAS AND BILIARY TRACT Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profi ling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Infl ammatory Process (2010) (5)
764 International Consensus Recommendations on the Management of Patients With Increased Risk for Familial Pancreatic Cancer: Cancer of the Pancreas Screening Consortium (CAPS) 2011 Summit (2012) (5)
Substance P and Neprilysin in Chronic Pancreatitis (2012) (5)
Pancreas: Postoperative pancreatic fistula: use of enteral nutrition (2011) (5)
Non-functioning Islet Cell Tumors - A Consideration of 8 Cases (1985) (5)
Laser Treatment (imILT) of Pancreatic Cancer: Safety and Feasibility Results From Two Phase 2a Studies. (2020) (5)
The evolution of surgical strategies for pancreatic neuroendocrine tumors (2017) (5)
Hospital readmission after distal pancreatectomy is predicted by specific intra- and post-operative factors. (2017) (5)
The emotional impact of surveillance programs for pancreatic cancer on high‐risk individuals: A prospective analysis (2020) (5)
The "natural" history of pain in chronic pancreatitis. (2000) (5)
ICAT is a novel Ptf1a interactor that regulates pancreatic acinar differentiation and displays altered expression in tumours. (2013) (5)
Pleomorphic Liposarcoma of the Axilla Metastatic to the Pancreas (2009) (4)
Combined derivatization and high-performance liquid chromatography with fluorescence and ultraviolet detection for simultaneous analysis of octreotide and gabexate mesylate metabolite in human pancreatic juice samples. (2015) (4)
Treatment of infected pancreatic necrosis without surgery (1992) (4)
A multicenter, randomized, controlled study of CO-1.01 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) and low tumor expression of human equilibrative nucleoside transporter-1 (hENT1) determined by metastasis biopsy. (2011) (4)
Prophylactic pylorus-preserving gastric transposition in unresectable carcinoma of the pancreatic head. (2004) (4)
Appraisal of the surgical management for pancreatic serous cystic neoplasms (2013) (4)
Early graft injuries after pancreatic transplantation in syngeneic rats. Cytoprotective effects of gabexate-mesilate. (1991) (4)
Liver Tumor Burden in Pancreatic Neuroendocrine Tumors: CT Features and Texture Analysis in the Prediction of Tumor Grade and 18F-FDG Uptake (2020) (4)
ESPAC-1: A European, randomised study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer (2001) (4)
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer (2021) (4)
Radiotherapy and chemotherapy in pancreatic cancer. Topical issues and future perspectives. (2006) (4)
Serous Cystic Neoplasms of the Pancreas Management in the Real-world (2020) (4)
Two hundred consecutive patients treated with radiofrequency ablation for stage III pancreatic cancer: Results from a single institution (2015) (3)
Kinetics of postoperative drain fluid amylase values after pancreatoduodenectomy: New insights to dynamic, data-driven drain management. (2021) (3)
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma. (2020) (3)
CT Simplified Radiomic Approach to Assess the Metastatic Ductal Adenocarcinoma of the Pancreas (2021) (3)
Microbiological Aspects of Pancreatic Fistulas (1992) (3)
The evolution of surgical strategies for pancreatic neuroendocrine tumors (Pan-NENs): Time-trend and outcome analysis from 587 consecutive resections (2018) (3)
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial. (2022) (3)
Clinical Manifestations and Therapeutic Management (2003) (3)
Evolving Techniques in Pancreatic Surgery (2016) (3)
Results of a multicenter clinical trial of pefloxacin versus imipenem in severe pancreatitis (1998) (3)
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors. (2020) (3)
Staging of pancreatic cancer: Suggestions for a simplified, reliable modification of the TNM classification system (1995) (3)
Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol (2022) (3)
Role of Somatostatin and Its Analogues in Gastrointestinal Fistulas, Ascites and Pancreatic Pseudocysts (1994) (3)
Laser Treatment of Pancreatic Cancer with Immunostimulating Interstitial Laser Thermotherapy Protocol: Safety and Feasibility Results From Two Phase 2a Studies (3)
Seasonal variations in pancreatic surgery outcome A retrospective time-trend analysis of 2748 Whipple procedures (2020) (3)
Resection in chronic pancreatitis: anastomosis with the jejunum or with the stomach? (2000) (3)
Surgical management of acute pancreatitis in Italy: lessons from a prospective multicentre study. HPB (Oxford), 2010; 12(9): 597-604. (2010) (3)
Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial. (2021) (3)
Vanishing Pancreatic Cysts during Follow-Up: Another Step Towards De-Emphasizing Cyst Size as a Major Clinical Predictor of Malignancy (2017) (3)
Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. (2019) (3)
A triple approach strategy for patients with locally advanced pancreatic adenocarcinoma. (2011) (3)
Role of Complete Parenteral Treatment Nutrition in Acute Pancreatitis (1982) (3)
Antibiotics in severe pancreatitis: the current status (1999) (3)
Distal Pancreatectomy Fistula Risk Score (D-FRS) (2022) (3)
DEFINING EARLY ORGAN FAILURE IN ACUTE PANCREATITIS: A PROSPECTIVE INTERNATIONAL MULTICENTER EVALUATION OF THE SOFA-VERSUS THE MARSHALL-SYSTEM (2007) (3)
Love (Pancreatic Surgery) in the Time of Cholera (COVID-19) (2020) (3)
[Gabexate mesilate vs gabexate mesilate combined with octreotide in the prevention of postoperative complications of pancreatic surgery: preliminary results]. (2001) (3)
Surgical and oncological outcomes after neoadjuvant FOLFIRINOX chemotherapy for (borderline) resectable and locally advanced pancreatic cancer: a pan-European cohort (2019) (3)
Octreotide in Preventing Complications from Pancreatic Surgery (1996) (3)
Robotic Distal Pancreatectomy: Is Hybrid Operation a Viable Approach? (2012) (3)
BRANCH DUCT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS OF THE PANCREAS (IPMNS): CONFIRMED FINDINGS IN 145 RESECTED PATIENTS (2006) (2)
958 - Splenectomy During Distal Pancreatectomy: What are we Really Doing? (2018) (2)
ROR1 and ROR2 expression in pancreatic cancer (2021) (2)
Surgery for chronic pancreatitis: the comparison of two high-volume centers reveals lack of a uniform operative management (2021) (2)
Pan-European survey on laparoscopic pancreatic surgery (2015) (2)
[Bilemia: diagnosis and conservative treatment. Apropos of a case complicated by hepatic abscess]. (1983) (2)
Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter study (2021) (2)
Migratory Necrolytic Dermatitis Presenting after Cephalosporin Administration in a Patient with a Pancreatic Head Mass (2004) (2)
Drugs Inhibiting Exocrine Pancreatic Section (1992) (2)
Postoperative Serum Hyperamylasemia (POH) Adds Sequential Value to the Fistula Risk Score (FRS) in Predicting Pancreatic Fistula after Pancreatoduodenectomy. (2022) (2)
Low Frequency of Follow-Up Examinations in the Initial Years From the Diagnosis of Low-Risk Pancreatic BD-IPMNs: The Right Choice? (2017) (2)
Routine prophylactic abdominal drainage versus no-drain strategy after distal pancreatectomy: A multicenter propensity score matched analysis. (2022) (2)
PROSPECTIVE INTERNATIONAL MULTICENTER EVALUATION OF THE SOFA,-APACHEII- AND MOF-SCORE IN PREDICTING MAJOR COMPLICATIONS AND OVERALL PROGNOSIS IN SEVERE ACUTE PANCREATITIS. (2004) (2)
Drain management following pancreatoduodenectomy: Reappraisal of a prospective randomized trial using risk stratification (2016) (2)
Pitfalls of Medical Treatment (1992) (2)
OC.11.2: RISK FACTORS FOR INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM (IPMN) OF THE PANCREAS: PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN MULTICENTRE CASE-CONTROL STUDY (2011) (2)
A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature. (2016) (2)
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma (2022) (2)
487 Fistula Risk Assessment for Pancreatoduodenectomy: A Call for Consensus (2015) (2)
Laparoscopic distal pancreatectomy: Analysis of trends in surgical techniques, patient selection, and outcomes. (2014) (2)
Risk factors for intraductal papillary mucinous neoplasm (Ipmn) of the pancreas: Results of the AISP (Italian Association for the Study of the Pancreas) Multicentre case-control study (2012) (2)
10 Pancreogastro Anastomosis Is Associated With a More Severe Derangement of Pancreatic Function and a More Marked Reduction of Pancreatic Volume Than Pancreojejunal Anastomosis. Results of a Long-Term Follow-Up Study After Duodenopancreatectomy (2014) (2)
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms. (2022) (2)
The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging (2017) (2)
Radiofrequency ablation of Locally Advanced Pancreatic Cancer: Immunostimulation Patterns (2019) (2)
Erratum to: Laparoscopic Pancreatectomy for Solid Pseudo-Papillary Tumors of the Pancreas is a Suitable Technique; Our Experience with Long-Term Follow-up and Review of the Literature (2010) (2)
401 consecutive minimally invasive distal pancreatectomies: lessons learned from 20 years of experience (2022) (2)
Paraduodenal Pancreatitis: An Italian Experience on 112 Patients (2013) (2)
Warshaw's technique: what's the point? (2012) (2)
Gα15 in early onset of pancreatic ductal adenocarcinoma (2021) (2)
Piperacillin-Tazobactam Penetration into Human Pancreatic Juice (2008) (2)
Intraoperative Blood Loss Estimation in Hepato-pancreato-biliary Surgery—Relevant, Not Reported, Not Standardized (2022) (2)
Different Ideas of Nodal Grouping in Standard and Extended Lymphadenectomy During Pancreaticoduodenectomy for Pancreatic Head Cancer. (2017) (2)
Complications After Pancreaticoduodenectomy: Analysis of Risk Factors, Their Incidence, and Possible Prevention in Italy (1997) (2)
Definition and classification of pancreatitis (2017) (1)
[Does locoregional chemotherapy improve survival in patients with non-resectable pancreatic carcinoma? Results of an open controlled study]. (2001) (1)
Does size matter? Reappraisal of tumour dimension as a predictor of outcome in resectable pancreatic cancer beyond the TNM (2016) (1)
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in human pancreas (2001) (1)
482 Discordance Between Perioperative Antibiotic Treatment and Wound Infection Cultures in Patients Undergoing Pancreaticoduodenectomy: A Multicenter 5-Year Study (2015) (1)
Pancreatic tumors : achievements and perspectives (2000) (1)
Survival and quality of life (QoL) of patients in ESPAC-1: A european, randomised study of assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer (2001) (1)
Computed tomography-based radiomic to predict resectability in locally advanced pancreatic cancer treated with chemotherapy and radiotherapy (2022) (1)
Postoperative Management in Patients Undergoing Major Pancreatic Resections (2018) (1)
Preoperative diabetes mellitus does not impact on postoperative morbidity after pancreatic resections for ductal adenocarcinoma (2012) (1)
Clinical implications of the 2016 International Study Group on Pancreatic Surgery (ISGPS) definition and grading of postoperative pancreatic fistula on 775 consecutive pancreatic resections (2017) (1)
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma (2021) (1)
[Parenteral and enteral nutrition in esophageal stenosis. Initial clinico-experimental results]. (1983) (1)
VOLATILE ORGANIC COMPOUNDS IN BREATH IN PATIENTS WITH PANCREATIC TUMOR. A PRELIMINARY CASE-CONTROL PROSPECTIVE STUDY (2006) (1)
Comment on "Main Duct Dilatation Is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas". (2019) (1)
Hemodynamics and remodeling of the portal confluence in patients with malignancies of the pancreatic head: a pilot study towards planned and circumferential vein resections (2021) (1)
Preoperative risk score for pancreatic fistula after distal pancreatectomy: Derivation and multicenter external validation (2017) (1)
Exploring the utility of early drain removal following distal pancreatectomy: a propensity score matched analysis (2018) (1)
Selective agenesis of pancreatic isthmus parenchyma with preservation of main pancreatic duct continuity, a very rare entity: Case report (2014) (1)
The faith of non-surveilled pancreatic cysts: a bicentric retrospective study. (2021) (1)
Pancreatic Fistulas: What Does the Future Hold in Store? (1992) (1)
Perioperative outcome of minimally invasive spleen-preserving distal pancreatectomy: Results of a multicenter survey in Italy (2013) (1)
High hENT1 expression is predictive of response of to adjuvant gemcitabine for pancreatic ductal adenocarcinoma patients randomized to adjuvant therapies in the ESPAC trials (2013) (1)
Spleen-Preserving Distal Pancreatectomy with and without Preservation of the Splenic Vessels (2018) (1)
The natural history of intraductal papillary mucinous neoplasms of the pancreas: Reappraisal of the indolent precursor of pancreatic cancer (2018) (1)
Adjuvant chemotherapy after surgery for invasive Intraductal papillary mucinous neoplasms of the pancreas: the potential survival benefit depends on the specific subtype (2018) (1)
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting. (2020) (1)
Delayed gastric emptying after pancreatoduodenectomy: One complication, two different entities. (2023) (1)
High-risk Pancreatic Anastomosis Versus Total Pancreatectomy After Pancreatoduodenectomy (2021) (1)
Nucleotide transporters and dCK1 as prognostic markers for patients with resected pancreatic ductal adenocarcinoma with or without adjuvant gemcitabine or 5FU hENT1 tested with samples from patients randomized in the ESPAC1/3 trials (2012) (1)
Pharmacokinetics of metronidazole (MZ) in patients with pancreatic fistula. (1987) (1)
Adjuvant chemotherapy in patients with resected pancreatic cancer following neoadjuvant FOLFIRINOX chemotherapy: an international multicenter study (2020) (1)
[Pancreaticoduodenectomy for cancer]. (2008) (1)
Distal Pancreatectomy With or Without Splenectomy: Indications, Pitfalls and Long Term Outcomes. Results of A Single Center Consecutive Series of 95 Laparoscopic Distal Pancreatectomies (2012) (1)
Prevalence of depression in a cohort of 400 patients with pancreatic neoplasm attending day hospital for major surgery: Role on depression of psychosocial functioning and clinical factors (2020) (1)
Postoperative serum hyperamylasemia (POH) predicts additional morbidity after pancreatoduodenectomy: It is not all about pancreatic fistula. (2022) (1)
P.1.205: WIRSUNGOCELE: A RARE CAUSE OF SEVERE NECROTIC ACUTE PANCREATITIS (2011) (1)
Size of Pancreatic Neuroendocrine Tumors Correlates with Risk of Lymph Node Metastasis (2017) (1)
Incidence and Risk Factor of New-Onset Diabetes After Distal Pancreatectomy (2018) (1)
Erratum: ProInf-AISP (Progetto Informatizzato Pancreatite Acuta, Associazione Italiana per lo Studio del Pancreas [Computerized Project on Acute Pancreatitis, Italian Association for the Study of the Pancreas]) Study Group (HPB (2010) 15 (597-604)) (2015) (1)
Sarcopenia and sarcopenic obesity in pancreatic ductal adenocarcinoma (PDAC) patients undergoing surgery after neoadjuvant therapy (NAT): Clinical implications. (2020) (1)
outcomes and risk score for distal pancreatectomy with celiac axis resection (DP-CAR score): An international multicenter analysis (2018) (1)
Pure biliary leak vs. pancreatic fistula associated: non-identical twins following pancreatoduodenectomy. (2022) (1)
nITRO: A phase 2 study of perioperative liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) in patients with resectable pancreatic ductal adenocarcinoma (rPDAC). (2023) (1)
[Clinical evolution of chronic pancreatitis and quality of life]. (2000) (1)
EDS Society News (2006) (1)
967 Main-Duct and Combined IPMNs Are the Same Clinical Entity and Distinct from Branch-Duct IPMNs (2009) (1)
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association (2021) (1)
Pancreatoduodenectomy associated with colonic resections: indications, pitfalls, and outcomes (2021) (1)
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours. (2022) (1)
Treatment of infected pancreatic necrosis without surgery. A reported case. (1992) (1)
Decoding grade B pancreatic fistula: a clinical and economical analysis and sub-classification proposal (2018) (1)
Minimally invasive versus open distal pancreatectomy for ductal adenocarcinoma (DIPLOMA): A European propensity score matched study (2017) (1)
Behavior ofAntibiotics during HumanNecrotizing Pancreatitis (1994) (1)
In reply to "Pancreatic surgery 101. Drain, no drain, early drain removal or late drain removal. What are the data? Where do we go from here". (2011) (1)
Author Correction: Pan-cancer analysis of whole genomes (2023) (1)
Systemic gemcitabine and capecitabine plus intra-arterial epirubicin and cisplatin as second-line chemotherapy in gemcitabine-failure pancreatic cancer. (2011) (1)
Loss of FGFR4 promotes the malignant phenotype of PDAC (2022) (1)
Mutation and Polymorphism Report (2000) (1)
BIOIMPEDANCE VECTOR ANALYSIS (BIVA) PREDICTS MORBIDITY FOLLOWING PANCREATIC RESECTION FOR CANCER (2019) (1)
Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study (2018) (1)
Perspectives of International Association of Pancreatology (IAP)/European Pancreas Club (EPC) consensus review of guidelines for the future studies on clinical management of pancreatic cancer (2015) (1)
Routes of nutrition for pancreatic fistula after pancreatoduodenectomy: a prospective snapshot study identifies the need for therapy standardization. (2022) (1)
Role of unlabelled somatostatin analogues in the prevention of complications after elective pancreatic and peripancreatic surgery: a critical review. (2004) (1)
Association Between Pancreatic IPMNs and Extra-pancreatic Malignancies (2014) (1)
[Cystic tumors of the pancreas: diagnosis, management and results]. (2008) (1)
781 Tissue and Serum Levels of Substance P Correlate in Patients with Chronic Pancreatitis (2008) (0)
Minutes of the 3rd General Assembly of European Digestive Surgery (EDS) (1999) (0)
Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis A Single-Center, Phase 3, Randomized Clinical Trial (2020) (0)
It is not necessary to resect all mucinous cystic neoplasms of the pancreas: current guidelines do not reflect the actual risk of malignancy. (2022) (0)
CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms (2019) (0)
Effects of hyperbaric oxygen exposure (HBO) in patients before surgical pancreatoduodenectomy. (2013) (0)
The Biological Effects of Preconditioning Hyperbaric Oxygen Therapy in Pancreaticoduodenectomy: Results of a Randomized, Double-Blind Trial in Humans (2013) (0)
[Segmental transplantation of the pancreas in juvenile diabetes: clinical experience at the Munich Transplantation Center]. (1987) (0)
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol (2022) (0)
[A case of choleretroperitoneum (clinical study)]. (1980) (0)
The prognostic impact of para-aortic lymph node metastasis in pancreatic cancer: A systematic review and meta-analysis (2016) (0)
Evidence of glucose absorption in a neoformed intestine (2022) (0)
Authors' reply: Enucleation of pancreatic neoplasms (Br J Surg 2007; 94: 1254–1259) (2008) (0)
Immune performance profile in pancreatic adenocarcinoma patients. (2010) (0)
Pancreatic texture study (PaTeSt). Preliminary results of intraoperative elastic module measurement (2012) (0)
The lesson learned in 20 years of minimally invasive distal pancreatectomy: Techniques and results in 282 consecutive procedures. (2020) (0)
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma (2022) (0)
Reinforced stapler vs. ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: a propensity-matched analysis (2020) (0)
Contents Vol. 30, 2013 (2014) (0)
Laparoscopic and Robot-Assisted Surgery for Pancreatic Neuroendocrine Tumors: Single-Center Experience (2013) (0)
Contents, Vol. 33, 1987 (1987) (0)
Cystic Pancreatic Lesions Beyond the Guidelines: Can we Make an Evidence-Based Decision Whether to Resect or to Observe? (2015) (0)
Pancreaticogastrostomy versus pancreaticojejunostomy: from randomized controlled trials to clinical practice (2016) (0)
Fine-needle aspiration of suspected pancreatic neuroendocrine tumors: a reliable tool to assess diagnosis and grading - A prospective single-center analysis of 100 cases (2019) (0)
High Values of Drain Fluid Epidermal Growth Factor and Transforming Growth Factor-Beta Are Associated with the Development of Pancreatic Fistula after Pancreatoduodenectomy (2022) (0)
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma (2018) (0)
Postoperative infectious complications as potential negative predictors: Analysis of 600 consecutive pancreaticoduodenectomies (2016) (0)
Immunological profile of systemic effects after radiofrequency ablation of locally advanced pancreatic cancer: Study design and preliminary results (2018) (0)
Chapter 15 PiUalls of Medical Treatment (1992) (0)
[Our experience with selective proximal vagotomy]. (1982) (0)
Do antibiotics have a role in the management of severe pancreatitis (2006) (0)
Surgical and Interventional Perspective in Chronic Pancreatitis (2009) (0)
The PANcreatic DISEASE ReseArch (PANDoRA) consortium: an update (2013) (0)
Contemporary Outcome Measures in Pancreatic Surgery (2018) (0)
Jeremy Jass Prize for Research Excellence in Pathology 2014 (2016) (0)
Non-inferiority of open passive drains compared with closed suction drains in pancreatic surgery outcomes: A prospective observational study (2018) (0)
T1743 Quality of Life in Long-Term Survivors After Pancreaticoduodenectomy (2008) (0)
European Adjuvant Trials (2002) (0)
[Syndrome caused by extrinsic compression of the celiac trunk (apropos of 4 cases)]. (1980) (0)
Tumour thrombosis: an uncommon finding associated with pancreatic tumours (2016) (0)
AB005. S005. A multiinstitutional postoperative nomogram for disease recurrence following resection of localized G1/G2 pancreatic neuroendocrine tumors (2018) (0)
Subject Index Vol. 11, 1994 (1994) (0)
Predictors of postoperative outcome after distal pancreatectomy: The answer from two high-volume institutions (2015) (0)
A New Method to Detect Pancreatic Ductal Adenocarcinoma by Analysis of Volatile Organic Compounds (VOCs) in Alveolar Air (2012) (0)
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma (2021) (0)
Resection in Cancer: Lymph Node Dissection (1999) (0)
Erratum: The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging (2018) (0)
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study (2022) (0)
Discrepancy between radiologic and pathologic measuraments in pancreatic neuroendocrine tumors: A retrospective study on 199 patients (2015) (0)
Author response to: Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours. (2022) (0)
Pancreatic Fistulas after Pancreaticoduodenectomy or Distal Pancreatectomy (2009) (0)
Prognostic value of mural nodules and their size in IPMN of the pancreas: high-volume center experience, systematic review and meta-analysis (2017) (0)
Pharmacodynamics of antibiotics in the pancreas. In “Metodi Innovativi in Farmacologia” (1997) (0)
ESPAC Satellite Symposium (1997) (0)
Antibiotics penetration in human necrotizing pancreatitis (NP). (1992) (0)
Long-term organoid culture of a small intestinal neuroendocrine tumor (2023) (0)
Pancreatic cancer surveillance program does not impact negatively on the psychological status of subjects enrolled (2019) (0)
Faculty of 1000 evaluation for Effect of a comprehensive surgical safety system on patient outcomes. (2010) (0)
Alagille Syndrome and the Notch Signaling Pathway: New Insights Into Human Development (1999) (0)
411 - Evolving the Paradigm of Early Drain Removal Following Pancreatoduodenectomy (2018) (0)
Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study (2022) (0)
Subject Index Vol. 6, 2006 (2007) (0)
Up front RFA for locally advanced pancreatic cancer: Short and long term results (2012) (0)
Bicentric experience and comparison between parenchyma-sparing and standard pancreatectomies for presumed non invasive IPMNs (2018) (0)
T03.01.10 RELIABILITY OF THE DIAGNOSTIC WORK-UP IN A PROSPECTIVE SERIES OF OPERATED CYSTIC PANCREATIC NEOPLASMS: A REAL-LIFE SCENARIO (2020) (0)
Prognostic Factors After Pancreatectomy for Pancreatic Cancer Initially Metastatic to the Liver (2022) (0)
The prognostic role of fatigue, depression and anxiety on postoperative outcomes after pancreatectomy for pancreatic cancer. A prospective observational study (FAT-PRO study). (2022) (0)
[Integrated project for the translational research on pancreatic ductal carcinoma]. (2002) (0)
What is the optimal management of paraduodenal pancreatitis? Surgery is associated with higher incidence of diabetes but similar quality of life and pain control (2020) (0)
ESPAC Satellite Symposium (1997) (0)
Postoperative Portal, Mesenteric, and Splenic Vein Thrombosis (2015) (0)
NMR and MRCP After Secretin Infusion in a Long-Term Comparison Study of Pancreogastro- vs. Pancreojejuno-Duodenopancreatectomy (2012) (0)
[2 cases of enterorrhagia caused by Meckel's diverticulum. Problems of diagnosis and therapy]. (1983) (0)
Alternative Fistula Risk Score for Pancreatoduodenectomy ( aFRS ) nal External Validation Design and Internatio (2017) (0)
The clinical and economic impact of surgical site infections after distal pancreatectomy. (2021) (0)
[Vascular complications of exostosing disease: one case of popliteral pseudoaneurysm (author's transl]. (1978) (0)
'Trivial' cysts redefine the risk of cancer development in presumed branch-duct ipmn of the pancreas: a potential target for follow-up discontinuation? (2020) (0)
Preoperative adipose tissue at Bioimpedance Vector Analysis (BIVA) predicts the occurrence of clinically relevant pancreatic fistula after pancreatoduodenectomy (2020) (0)
The Experience Factor for Pancreatoduodenectomy: Extending Quality Improvement within the High Volume Setting (2021) (0)
Type of reconstruction after pancreaticoduodenectomy : where are we going? An attempt of answer in a single high volume centre (2005) (0)
Author and Subject Index (1999) (0)
Incidence, risk factors, treatment and outcome of post-pancreaticoduodenectomy biliary fistula (2016) (0)
[Contribution of computerized axial tomography in the study of splenic injuries]. (1983) (0)
P.1.30: SECONDARY CANCERS IN PATIENTS WITH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE PANCREAS (IPMN): PRELIMINARY RESULTS OF A PROSPECTIVE MULTICENTRE ITALIAN STUDY (2011) (0)
Rectal swab culture can direct antimicrobial prophylaxis and predict the risk of infectious complications after Pancreaticoduodenectomy (2017) (0)
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience (2022) (0)
[Pancreas transplant today: review of the literature]. (1986) (0)
Reappraisal of nodal staging and study of lymph node station involvement in patients receiving pancreaticoduodenectomy after neoadjuvant treatment for pancreatic ductal adenocarcinoma (2020) (0)
Response to: Re: Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS). (2020) (0)
Wound protector dual-ring AlexisⓇ in Pancreaticoduodenectomy: A randomized single-blind controlled clinical trial (PALEXIS trial) (2020) (0)
Pancreatic pure hepatoid carcinoma: A review of the literature (2012) (0)
Table I, Early complications in SAP (within the first 2 weeks) (2001) (0)
Prevention of variceal rebleeding during the course of endoscopic injection sclerotherapy (EIS): A randomized pilot trial testing nadolol (N) (1990) (0)
101PA circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma (2017) (0)
The role of a dedicated surgical meeting to implement the level of care at a High-Volume Pancreatic Center: a before-after analysis (2020) (0)
Pancreatic Frozen Section in Distal Pancreatectomy: Verona Experience with Harmonic Focus® (2013) (0)
768 CLINICALLY RELEVANT PANCREATIC FISTULA FOLLOWING PANCREATODUODENECTOMY IS ASSOCIATED WITH HIGH INTRAOPERATIVE BLOOD LOSS: AN INTERNATIONAL, MULTI-INSTITUTIONAL PROPENSITY SCORE MATCHED ANALYSIS. (2021) (0)
Postoperative acute pancreatitis following pancreaticoduodenectomy: a determinant of fistula driven by the intraoperative fluid management (2018) (0)
Long-Term Follow-Up after Surgery for Chronic Pancreatitis: A Bicentric Retrospective Experience (2022) (0)
Reappraisal of main pancreatic duct in IPMN under surveillance: dilatation alone is not an absolute indication for surgery (2018) (0)
M1544 Quality of Life After Total Pancreatectomy: Requiem for a Surgical Dogma? (2008) (0)
Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma (2017) (0)
ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma. (2009) (0)
Radiofrequency ablation of locally advanced pancreatic cancer: Is there a role for SMAD4 analysis in the selection of patients? (2016) (0)
[Update in transplant surgery with special reference to the problem of organ donation]. (1987) (0)
PROGNOSTIC VALUE OF PREOPERATIVE NUTRITIONAL STATUS IN RESECTED PANCREATIC DUCTAL ADENOCARCINOMA: A PROSPECTIVE STUDY (2020) (0)
43 Long-Term Outcomes of IPMNs With Consensus Guidelines Criteria for Resection Undergoing Nonoperative Management (2015) (0)
The number of positive nodes accurately predicts recurrence after distal pancreatectomy for nonfunctioning neuroendocrine neoplasms (2020) (0)
Preoperative nutritional status as predictor of complication after pancreatic surgery: High volume center experience (2018) (0)
Number of harvested lymph nodes and stage migration effect in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: Reappraising the standards based on the Eighth Edition of the American Joint Committee on Cancer (2019) (0)
Prevention and management of complications after ablative therapies on the pancreas (2017) (0)
Preoperative serum CA19.9 independently predicts resectability and survival in pancreatic cancer of the body-tail (2020) (0)
Post operative acute pancreatitis (POAP) is a major predictor of pancreatic fistula after distal pancreatectomy (2020) (0)
Synchronous superior mesenteric-portal vein resection during pancreatectomy for T3 head adenocarcinoma: Perioperative outcomes and prognostic implications of histologically confirmed venous infiltration (2016) (0)
A new tool for objective assessment of pancreatic texture predicts postoperative pancreatic fistula (2016) (0)
[Pseudocystic pleural fistula documented by retrograde cholangiopancreatography]. (1980) (0)
Survival and complications of pancreatectomy following FOLFIRINOX chemotherapy in borderline resectable and locally advanced pancreatic cancer: A pan-European cohort (2020) (0)
Faculty Opinions recommendation of Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival. (2006) (0)
Contents Vol. 18, 2001 (2001) (0)
Clinical Strategy In Severe Hemorrhage Due To Pancreatic Pseudocysts (1986) (0)
Subject Index Vol. 58, 1997 (2004) (0)
The Outbreak of Multidrug-Resistant Klebsiella pneumoniae in a High Volume Pancreatic Surgery Unit (2013) (0)
OC.11.6: IN PATIENTS WITH PANCREO-DUODENAL RESECTION, PANCREO-GASTRO ANASTOMOSIS PRODUCES A MORE SEVERE PANCREATIC DERANGEMENT THAN PANCREO-JEJUNAL ANASTOMOSIS. RESULTS OF A LONG TERM RANDOMISED STUDY (2011) (0)
Non-Adenocarcinoma Pancreatic Tumors (2001) (0)
The spectrum of Intraductal tumours (2000) (0)
Subject Index Vol. 60, 1999 (1999) (0)
Pancreatic Surgery Definition and Grading of Postoperative secutive Pancreatic Resections Pancreatic Fistula on 775 Con (2017) (0)
Undetermined cystic lesions of the distal pancreas: When resection is not warranted regardless of the diagnosis (2016) (0)
The PANcreatic Research (Pandora) Consortium: An update. (2013) (0)
[Chronic pancreatitis]. (1970) (0)
Chapter 13 Drugs Inhibiting Exoerine Panereatie Seetion (1992) (0)
Diagnosis of Infected Pancreatic Necrosis (1997) (0)
Sa1518 Precut Sphincterotomy At a Tertiary Referral Center for Pancreatic Diseases: A Prospective Study (2011) (0)
Front & Back Matter (2012) (0)
Twice-weekly gem and concurrent RT in patients with advanced pancreatic cancer (2006) (0)
[Cavitary carcinomas of the lung with a pseudocystic aspect. Description of 2 clinical cases]. (1980) (0)
Corrigendum: Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory Process (2011) (0)
Antibiotics Secretion into Pancreatic Fluid (1992) (0)
Reappraisal of main pancreatic duct in IPMN under surveillance: duct dilatation of 5 to 9 mm alone is not associated with high cancer risk (2018) (0)
Acute pancreatitis after pancreatoduodenectomy: A prospective study of diffusion-weighted magnetic resonance imaging, serum biomarkers, and clinical features. (2023) (0)
Intestinal failure J. Nightingale (ed.) 250 × 190 mm. Pp. 565. 2001. London: Greenwich Medical Media. £85.00. (2002) (0)
Use of Operative Sonography In Carcinoma of the Pancreas (1988) (0)
Chemotherapy and subsequent stereotactic body radiotherapy (SBRT) as a multimodal neoadjuvant approach for selected borderline resectable / locally advanced pancreatic adenocarcinoma (2019) (0)
ESGAR 2018 Book of Abstracts (2018) (0)
Anastomotic leakeage in pancreatic surgery (2007) (0)
The role of age in the management of IPMNs of the pancreas: same risk of cancer-related death but different implications for the management (2018) (0)
Results of a surveillance protocol for pancreatic BD-IPMNs (2013) (0)
Complications After Pancreatic Surgery (2021) (0)
Clinical impact of sarcopenia and sarcopenic obesity in pancreatic ductal adenocarcinoma (PDAC) patients undergoing surgery after neoadjuvant therapy (NAT) (2020) (0)
Mo1511 Predictive Factors of Pancreatic Fistula and Postoperative Complications After Pancreatic Resections in Two High Volume Centers: Comparison Between Posterior Invagination and Duct-to-Mucosa Pancreaticogastrostomy (2012) (0)
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis (2023) (0)
Bicentric experience and comparison between parenchyma-sparing pancreatectomies and standard pancreatectomies for the management of presumed non invasiv IPMNs (2017) (0)
Author Correction: The evolutionary history of 2,658 cancers (2023) (0)
Low postoperative lymphocyte count as negative predictor of major complications in pancreatic resections (2016) (0)
Contents, Vol. 58, 1997 (1997) (0)
Hormonal Treatment of Pancreatic Fistulas (1993) (0)
Cancer of the Exocrine Pancreas: Surgery and Multimodal Treatment (2009) (0)
Role of inducible nitric oxyde synthase and cyclooxygenase-2 in human pancreatic adenocarcinoma (2007) (0)
Pancreatic Surgery in Patients with Concomitant Liver Cirrhosis: A Single Centre Experience (2013) (0)
[A case of duodenal duplication in the adult]. (1985) (0)
Contents, Vol. 58, 1997 (1997) (0)
Clinical Aspect of Complications: Features and Prognoses (2009) (0)
Pancreaticojejunostomy after Pancreaticoduodenectomy: Suture Material and Incidence of Post-Operative Pancreatic Fistula (2016) (0)
Contents (2020) (0)
Effect of Hyperbaric Oxygen Treatment and Gemcitabine on Apoptosis in Pancreatic Ductal Adenocarcinoma Cells (2013) (0)
Preliminary Microbiological and Antibiotic Kinetic-study On Prevention and Treatment of Pancreatic Infections (1986) (0)
Pancreatic ductal adenocarcinoma can be detected by analysis of volatile organic compounds (VOCs) in alveolar air (2018) (0)
Volume-Outcome Relationship in Pancreatic Surgery (2020) (0)
Outbreak of antibiotic-resistant klebsiella pneumoniae in a high-volume pancreatic surgery unit (2013) (0)
Short term chemotherapy followed by RFA: A new protocol for stage III pancreatic cancer? (2012) (0)
Downstaging of locally advanced pancreatic cancer after multimodal treatment (2018) (0)
A 13-Year Single Institution Experience with 4-Drug Regimens in Patients with Advanced Pancreatic Adenocarcinoma ( PA ) (2011) (0)
Number of harvested lymph nodes and stage migration effect in distal pancreatectomy for pancreatic ductal adenocarcinoma (2016) (0)
'Deep' enucleation of pancreatic neoplasms following endoscopic main pancreatic duct stenting: Operative technique and preliminary experience at two high-volume centers (2020) (0)
President’s Address at the General Assembly by John Wong, President CICD (1999) (0)
OC.09.5 PROGNOSTIC ROLE OF REGIONAL LYMPH NODE STATIONS IN RESECTED PANCREATIC HEAD DUCTAL ADENOCARCINOMA (2014) (0)
[Our experience in the field of splenic injuries]. (1980) (0)
ASO Visual Abstract: Prognostic Factors After Pancreatectomy for Pancreatic Cancer Initially Metastatic to the Liver (2022) (0)
Abstracts from the sixth meeting of the international association of pancreatology, November 2–4, 1994, Chicago, IL (1994) (0)
Screening programs for pancreatic cancer in familial high-risk individuals: A systematic review and meta-analysis of the prevalence of goals of screening achievement, overall and unnecessary surgery (2017) (0)
Surgery for Distal Cholangiocarcinoma (2016) (0)
Laparoscopic enucleation of benign and borderline pancreatic neoplasms (2013) (0)
Pancreatic Cystic Tumors : Verona Centre Experience. (2003) (0)
Chapter 11 Antibiotics Secretion into Pancreatic Fluid (1992) (0)
Management of Pancreatic and Duodenal Neuroendocrine Tumors (2018) (0)
Perfusion Changes in Liver Metastases (LM) from Pancreatic Neuroendocrine Tumors (PanNETs) during Everolimus (E) Treatment: Update of Perfusion CT (P-CT) Study (2015) (0)
Cytoreduction after radiofrequency ablation of unresectable pancreatic adenocarcinoma: correlation between CA 19.9 serum levels and necrosis extent at CT (2015) (0)
When and How to Follow Patients with Cystic Tumors of the Pancreas (2016) (0)
What is the optional management of groove pancreatitis? Surgery is associated with higher incidence of diabetes but similar quality of life (2018) (0)
474 ICAT is a Novel PTF1a Interactor That Regulates Acinar Differentiation and Displays Altered Expression in Pancreatic Ductal Tumors (2012) (0)
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma. (2022) (0)
A single-platform cyst fluid assay to predict IPMN with high-malignant potential for surgical resection: a multi-institutional international report (2017) (0)
Chapter 10 Microbiological Aspects of Pancreatic Fistulas (1992) (0)
Neurolytic celiac plexus block: results up to death in 73 patients with malignant pancreatic pain (1991) (0)
Antibiotic Prophylaxis for Acute Pancreatitis in Clinical Practice: Rationale, Indications, and Protocols for Clinical Practice (2007) (0)
Contents Vol. 2, 2002 (2002) (0)
Early onset predicts neither better surgical outcomes nor improved survival following resection for pancreatic ductal adenocarcinoma. (2021) (0)
1034: ANALYSIS OF RECURRENCE FOLLOWING POST-NEOADJUVANT PANCREATECTOMY IN RESECTABLE AND BORDERLINE RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA (2022) (0)
The prognostic significance of preoperative nutritional status in resected pancreatic ductal adenocarcinoma (PDAC) (2019) (0)
Beyond the numbers: The pattern of lymph node metastasis allows for distinguishing different N+ categories: Reappraisal of the Japanese classification of lymph node metastases in pancreatic adenocarcinoma (2016) (0)
Analysis of Risk Factors and Management of Biliary Strictures Following Pancreaticoduodenectomy (2010) (0)
746: A DYNAMIC ANALYSIS OF EMPIRICAL SURVIVAL OUTCOMES FOLLOWING PANCREATECTOMY FOR PANCREATIC DUCTAL ADENOCARCINOMA (2022) (0)
Long‐Term Outcome after Observation and Surgical Treatment of Cystic Neoplasms of the Pancreas (2015) (0)
Diagnosis and Differential Diagnosis of Pancreatic Cystic Tumors (2007) (0)
The actual incidence of symptoms due to pancreatic cystic neoplasms: Are we overestimating a major indication for surgery? A prospective propensity matched cohort analysis (2018) (0)
Chapter 64 – Pancreas as a site of metastatic cancer (2017) (0)
IS-741 (Ishihara Sangyo). (2001) (0)
Preoperative fecal elastase-1 (FE-1) correlates with pancreatic fistula after major pancreatic resections (2018) (0)
Development of a brief psychological intervention for the management of pre-surgical anxiety before pancreatic surgery (2018) (0)
A Single Centre Experience in Minimally Invasive Surgery for Pancreatic Cystic Lesions (2013) (0)
Invited papers - Clinical Trial Updates Session (2000) (0)
Periampullary Cancer ESPAC-3(v2) trial: a Randomised Controlled Phase III Trial of Adjuvant Chemotherapy Versus Observation in Patients With Periampullary Adenocarcinomas of the Head of the Pancreas (2011) (0)
732 – International Validation of the Amsterdam Model for Prediction of Survival After Resected Pancreatic Cancer (2019) (0)
[A case of suppurated urachal cyst (clinical study)]. (1980) (0)
PO-1048: Postoperative complications and margins status after neoadjuvant SBRT for pancreatic cancer (2020) (0)
[Pancreatic pseudocysts with unusual localization (clinical case reports)]. (1979) (0)
Necrosectomy and Closed Lavage in Acute Pancreatitis (1993) (0)
Basic science, translational research and surgery: an unresolved controversy (2013) (0)
Does the size of mural nodule matter to predict malignancy in BD-IPMN? A systematic review of the literature and single high-volume center experience (2016) (0)
Insights and Practice Habits from International Master Surgeons Regarding Pre- and Intra-operative Risk Assessment of Pancreatic Fistula During Pancreatoduodenectomy (2021) (0)
Gabexate Mesilate and Acute Pancreatitis (1994) (0)
MULTIFOCAL BRANCH-DUCT IPMNS: A NEW DEAL TO BE EXPLORED (2006) (0)
[The role of parenteral nutrition in the treatment of acute hemorrhagic necrotic pancreatitis and related complications; apropos of a case]. (1982) (0)
37th Annual Meeting of the American Pancreatic Association and 13th Meeting of the International Association of Pancreatology. November 1–4, 2006, Chicago, Ill. (2007) (0)
Subject Index Vol. 18, 2001 (2002) (0)
1st National Congress of the Hellenic Society of Digestive Surgery (2004) (0)
Erratum: Outcome and quality of life in chronic pancreatitis (Journal of the Pancreas (Online) (2001) vol. 2 (4) (117-123)) (2005) (0)
Branch duct intraductal papillary-mucinous neoplasia: Thin red line walking between surgery and surveillance (2012) (0)
Idiopathic acute recurrent pancreatitis: a prospective long-term follow-up (2001) (0)
Metronidazole (MZ) penetration into pancreatic juice (P5) and necrotic pancreatic tissue (NPT). (1992) (0)
Piperacillin-Tazobactam Penetration into Human Pancreatic Juice (cid:1) (2008) (0)
Subject Index Vol. 58, 1997 (2004) (0)
[Pancreatic fistulas: evaluation of medical treatment in 50 observed cases]. (1983) (0)
Chapter 52 – Definition and classification of pancreatitis (2012) (0)
Minimally Invasive Surgery for Pancreatic Neuroendocrine Tumors: Why Not? (2014) (0)
Cohort Study of the Incidence of Extrapancreatic Neoplasm During Clinical and Radiological Surveillance of Patients with Branch-Duct IPMN (2013) (0)
Impact of neoadjuvant therapy on pathological features and survival of resected pancreatic adenocarcinoma (2017) (0)
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy (2023) (0)
Erratum: Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: Gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process (American Journal of Gastroenterology (2010) 105 (2060-2071) DOI:10.1038/ajg.2011.141) (2011) (0)
Cystic Adenoma of the Pancreas - Diagnosis and Surgical-treatment (1987) (0)
Pefloxacin penetration during acute pancreatitis. (1994) (0)
Updates in the Management of Acute Pancreatitis (2019) (0)
Author Correction: Patterns of somatic structural variation in human cancer genomes (2020) (0)
External validation of the MDACC clinical classification system for pancreatic cancer in a European multicenter cohort (2019) (0)
Author Correction: Inferring structural variant cancer cell fraction (2022) (0)
Comparative genomic analysis on well-differentiated pancreatic neuroendocrine tumors with small size (< 3cm) reveals genetic alterations associated with distant metastases (2017) (0)
The 2016 update of the definition and grading of POPF: clinical validation on 775 consecutive pancreatic resections (2017) (0)
International validation of the updated international study group of pancreatic surgery definition of postoperative pancreatic fistula after distal pancreatectomy (2018) (0)
Tumor seeding after percutaneous US-guided FNA of solid pancreatic neoplasms (2016) (0)
Robotic distal pancreatectomy for pancreatic neuroendocrine tumors (pNETs) in Italy: multicentric survey on 54 patients (2016) (0)
Thank you to our reviewers (2020) (0)
nanostructure and function in neurons Effects of hyperbaric gases on membrane (2015) (0)
The Case for Surgery (2010) (0)
Pancreatic Decompression in Chronic Pancreatitis (2004) (0)
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (0)
Can bioimpedance vector analysis (BIVA) predict the surgical risk in cancer patients undergoing pancreatic surgery? (2018) (0)
OC.08.2 POORLY DIFFERENTIATED RESECTABLE PANCREATIC CANCER: AN INDICATION FOR NEOADJUVANT TREATMENT? (2012) (0)
[abstract]HYPERBARIC OXYGEN EXPOSURE (HBO2) IN PATIENTS BEFORE SURGICAL PANCREATO-DUODENECTOMY (WHIPPLE PROCEDURE): A RANDOMIZED, SINGLE-BLIND TRIAL (2013) (0)
Natural History of Intraductal Papillary Mucinous Neoplasm of the Pancreas Reappraisal of the Indolent Precursor of Pancreatic Cancer (2018) (0)
Staging of pancreatic ductal adenocarcinoma after neoadjuvant therapy: reappraisal of the prognostic accuracy of the AJCC 8th edition (2019) (0)
P.1.22: PRECUT SPHINCTEROTOMY AT A TERTIARY REFERRAL CENTER: A PROSPECTIVE STUDY (2011) (0)
T1584 Chronic Obstructive Pancreatitis Associated with Serous Cystic Tumors of the Pancreas: A New Issue to Be Explored (2009) (0)
International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for pancreatic cancer (2020) (0)
Prognostic impact of lymph node stations in pancreatico-duodenectomy for pancreatic head cancer (2014) (0)
Different Ideas of Nodal Grouping in Standard and Extended Lymphadenectomy During Pancreaticoduodenectomy for Pancreatic Head Cancer. (2017) (0)
Outcomes After Laparoscopic Enucleation of Pancreatic Neoplasms at a Single High Volume Italian Institution (2012) (0)
The role of age in pancreatic intraductal papillary neoplasms: same survival but different implications for the management (2018) (0)
The actual incidence of pancreatic cystic neoplasm related symptoms: are we overestimating a major indication for surgery? (2019) (0)
LBA.02.3 PERIOPERATIVE OUTCOME OF MINIMALLY INVASIVE SPLEEN-PRESERVING DISTAL PANCREATECTOMY: RESULTS OF A MULTICENTER SURVEY IN ITALY (2014) (0)
Consensus Statement on Mandatory Registration of Clinical Trials (2007) (0)
2nd Hellenic Congress of the Hellenic Society for Digestive Surgery (2006) (0)
CORRELATION BETWEEN BODY COMPOSITION, INFLAMMATION AND SURVIVAL IN PANCREATIC CANCER TREATED WITH NEOADJUVANT THERAPY (2020) (0)
Phospholipase Cγ-1 regulates cell migration in pancreatic cancer cells (2013) (0)
After pancreatoduodenectomy, pancreo-gastroanastomosis produces a greater impairment of residual function than pancreo-jejunostomy – Results of an 8 year follow-up (2012) (0)
[Closed surgical treatment in acute severe pancreatitis]. (1995) (0)
Open pancreaticoduodenectomy: setting the benchmark of time to functional recovery (2021) (0)
[Endobronchial lipomas]. (1982) (0)
Duodenal Duplications(dd) - A Unusual Cause of Chronic-pancreatitis (1986) (0)
Gα15 Potential as a Biomarker for Pancreatic Carcinoma (2012) (0)
Pancreatic cancer-associated diabetes is correlated with increased liver nitric oxide (NO) (2002) (0)
Immunity stimulation after radiofrequency ablation of locally advanced pancreatic cancer: Preliminary results (2016) (0)
Surgery after downstaging of Stage IV pancreatic carcinoma: are we facing a new scenario? (2019) (0)
Does any medical intervention modify outcome in patients with hepatic failure (2002) (0)
Clinically relevant pancreatic fistula: Risk factors and surgical strategy (2015) (0)
The Actual Incidence of Symptoms in Patients with Uancreatic Cystic Neoplasms: Are We Overestimating a Major Indication for Surgery? (2017) (0)
Surgical Management of Serous Cystic Neoplasms of the Pancreas (2015) (0)
The natural history of intraductal papillary mucinous neoplasm of the pancreas: Reappraisal of the indolent precursor of pancreatic cancer (2018) (0)
Surgical decompression of Wirsung duct reduces serum concentration of SPINK1 in patients with chronic pancreatitis. (2018) (0)
1560P Sarcopenia and sarcopenic obesity in pancreatic ductal adenocarcinoma (PDAC) patients undergoing surgery after neoadjuvant therapy (NAT): Prevalence and clinical implications (2020) (0)
Lymph Node Dissection for Small Pancreatic Neuroendocrine Tumors Does Not Impact Survival (2018) (0)
Reappraisal of Main Pancreatic Duct in Intraductal Papillary Mucinous Neoplasm under Surveillance: Dilation Alone Is Not an Absolute Indication for Operation (2018) (0)
Prevention of complications after pancreatic surgery TABLE I Postoperative complications used to evaluate octreotide efficacy in comparison with placebo Death * Leakage from anastomosis Pancreatic fistula Abscess Fluid collection Pancreatitis Shock Sepsis Respiratory failure Renal failure Bleeding * (0)
Time trends of lymphnode retrieval for pancreatic adenocarcinoma in a high volume center increased lymph node yield is not necessarily associated with a greater number of lymph node positive cancers (2016) (0)
3 DECISION-MAKING AND PRACTICE HABITS FROM INTERNATIONAL MASTER SURGEONS REGARDING POSTOPERATIVE DRAIN MANAGEMENT AND TREATMENT OF PANCREATIC FISTULA FOLLOWING PANCREATODUODENECTOMY. (2021) (0)
OR50: Bioimpedance Analysis to Predict Major Morbidity in Pancreatic Resection. The Key Role of Perioperative Interstitial Fluid Shift (2019) (0)
Response to the Comment on: "Letter to Editor Re Manuscript by Bannone et al." Ann Surg. 2018 Dec 20. (2019) (0)
Long-Term Outcome After Observation and Surgical Treatment (2018) (0)
Imipenem (IMP) penetration into pancreatic tissue during acute necrotizing form (NP). (1991) (0)
IS-4-4 Surgical approach to pancreatic cancer : Verona experience(Imanaga Memorial Symposium:Pancreaticoduodenectomy for pancreatic cancer,International Symposium(4)) (2010) (0)
Distal pancreatectomy with or without splenectomy: indications, pitfalls and long-term outcomes (2013) (0)
Cancer of the papilla of Vater: preoperative cryostatic examination of endoscopic biopsies to reduce risk and save time and money (1995) (0)
Intra-abdominal surgical drain dislocation: The unknown factor in the debate between drain vs. drainless policies (2017) (0)
Subject Index Vol. 2, 2002 (2002) (0)
Contents Vol. 6, 2006 (2007) (0)
Serous cystadenoma of the pancreas: a benign entity still representing indication for surgery in the real life (2020) (0)
Prevention of sepsis in acute pancreatitis (1996) (0)
Early graft injurie, after pancreatic transplantation insyngeneic rats (1991) (0)
How to Deal with a Periampullary Mass (2003) (0)
How should we go about staging cancer in the future (1996) (0)
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma (2020) (0)
Radical resection after radiofrequency ablation of locally advanced pancreatic carcinoma (2013) (0)
Up-Date in Pancreatic Surgery (2000) (0)
Long-term follow-up of resected small (< 2 cm) asymptomatic sporadic non-functioning pancreatic neuroendocrine tumors: Correlation between type of resection, histopathologic features, and outcome. (2014) (0)
Borderline resectable pancreatic cancer: The role of neoadjuvant chemotherapy to improve surgical outcome (2016) (0)
Prof. Carlo Procacci (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Claudio Bassi?

Claudio Bassi is affiliated with the following schools:

University of Liverpool
University of Calgary
University of Milan
MD Anderson Cancer Center
University of Verona
Stanford University
University of Glasgow